NCT06358885

Brief Summary

This study is a hybrid type 3, cluster randomized implementation trial to examine effective strategies to scale up the Brief Alcohol Intervention (BAI) in ART clinics in Vietnam. One arm will receive only facilitation for BAI implementation. Facilitation is a flexible strategy that helps clinics to address common barriers, such as counselor skills, competing priorities, and resource deficits. In the other arm, in addition to facilitation, clinic staff, irrespective of their own alcohol use, will be offered the BAI themselves as experiential learning (EBAI) to address their own alcohol-related attitudes and behaviors. Clinic staff responsible for delivering the BAI to patients will also be offered 3 consolidation activities to integrate their own experiences with their delivery of the BAI.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,234

participants targeted

Target at P75+ for not_applicable

Timeline
6mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Apr 2024Nov 2026

First Submitted

Initial submission to the registry

April 1, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 11, 2024

Completed
14 days until next milestone

Study Start

First participant enrolled

April 25, 2024

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

December 30, 2025

Status Verified

June 1, 2025

Enrollment Period

2.5 years

First QC Date

April 1, 2024

Last Update Submit

December 28, 2025

Conditions

Keywords

Alcohol interventionCluster randomized controlled implementation trialImplementation ScienceHIV/AIDSAntiretroviral therapyCognitive behavioral therapyMotivational InterviewingMotivational Enhancement TherapyCost AnalysisEconomic EvaluationVietnam

Outcome Measures

Primary Outcomes (2)

  • Fidelity Score

    Fidelity is a clinic-level measure assessed as a composite of the recipients of the BAI. The timeframe of 15 months reflects individual recruitment over 12 months plus 3 months for completion of the BAI. The score comprises successful completion of the 4 protocol-specified BAI sessions (2 in-person, 2 by phone) within 7 weeks of the initial session weighted by the central fidelity rater's quality rating of the in-person sessions. Fidelity will be assessed using a tailored selection of fidelity measures including the BAI Core Components Checklist. The clinic fidelity score ranges from 0-100. The score will be the percentage of counseling sessions completed, multiplied (weighted) by the combined average quality rating of counseling sessions. Higher scores indicate higher fidelity.

    15 months

  • Viral Suppression

    Viral suppression is defined as a viral load \<1000 copies/mL on a dried blood spot (DBS) sample collected 12 months after enrollment of a participant.

    12 months

Secondary Outcomes (10)

  • BAI Acceptability Score - Clinic Staff: Acceptability of Intervention Measure (AIM) scale

    Up to 12 months

  • BAI Acceptability score Counselors: Mental Health Implementation Science Tools (mhIST) Acceptability Scale for Providers

    Up to 12 months

  • BAI Acceptability PWH: Mental Health Implementation Science Tools (mhIST) Acceptability Scale for Consumers

    Up to 12 months

  • Penetration- Proportion of PWH Screened with the AUDIT-C

    Up to 12 months

  • Penetration - Proportion of PWH who screen positive who receive at least one counseling session

    Up to 12 months

  • +5 more secondary outcomes

Study Arms (2)

Facilitation Only (FAC)

ACTIVE COMPARATOR

Clinics randomized to the FAC arm will implement BAI delivery to PWH using the facilitation only approach.

Other: Facilitation (FAC)

Facilitation Plus an Experiential Brief Alcohol Intervention (EBAI+FAC)

EXPERIMENTAL

Clinics randomized to the EBAI+FAC arm will implement BAI delivery to PWH participants using the facilitation approach. Additionally, clinic staff, irrespective of their own alcohol use, will be offered the BAI themselves prior to delivering the BAI.

Other: Facilitation (FAC)Behavioral: Experiential Brief Alcohol Intervention (EBAI)

Interventions

The facilitation approach will use a flexible clinic level implementation strategy that helps clinics to address common barriers, such as counselor skills, competing priorities, and resource deficits.

Facilitation Only (FAC)Facilitation Plus an Experiential Brief Alcohol Intervention (EBAI+FAC)

Clinic staff will be offered the experiential BAI prior to implementation. The BAI comprises 2 in-person sessions and 2 booster phone sessions. Clinic staff responsible for delivering the BAI to PWH participants will be offered 3 additional consolidation sessions to integrate their experiences receiving the BAI with their delivery of the BAI.

Facilitation Plus an Experiential Brief Alcohol Intervention (EBAI+FAC)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • PWH cohort participants
  • Person living with HIV at any stage of HIV infection
  • Currently attending the study ART clinic at any ART stage (initiating or receiving ART)
  • AUDIT-C score \>=4 for men or \>=3 for women
  • \>= 18 years of age
  • Willing to provide informed consent, which includes consenting to interview and collection of dried blood spots
  • Clinic staff participants:
  • Work at the ART clinic as a clinic director, physician, nurse, or counselor
  • Willing to provide informed consent

You may not qualify if:

  • PWH cohort participants:
  • Psychological disturbance preventing participation
  • Cognitive impairment
  • Threatening behavior
  • Unwilling to provide locator information Note: If a participant screens positive with the AUDIT-C and is identified to be at substantial risk for alcohol withdrawal based on the Mini International Neuropsychiatric Interview (MINI) and Clinical Institute Withdrawal Assessment of Alcohol Scale (CIWA) will be referred for treatment. They will not be eligible for enrollment until after alcohol withdrawal concerns are addressed.
  • These participants may be rescreened, consented, and enrolled after treatment.
  • Clinic staff participants:
  • Psychological disturbance, cognitive impairment, or threatening behavior

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hanoi Medical University

Hanoi, Vietnam

Location

Related Publications (1)

  • Bartels SM, Phan HTT, Hutton HE, Nhan DT, Sripaipan T, Chen JS, Rossi SL, Ferguson O, Nong HTT, Nguyen NTK, Giang LM, Bui HTM, Chander G, Sohn H, Kim S, Tran HV, Nguyen MX, Powell BJ, Pence BW, Miller WC, Go VF. Scaling up a brief alcohol intervention to prevent HIV infection in Vietnam: a cluster randomized, implementation trial. Implement Sci. 2024 Jun 12;19(1):40. doi: 10.1186/s13012-024-01368-6.

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Interventions

EthanolMethods

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

AlcoholsOrganic ChemicalsInvestigative Techniques

Study Officials

  • Vivian Go, MD

    University of North Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: A two-arm cluster-randomized implementation trial comparing two strategies to scale-up an evidence-based brief alcohol intervention (BAI), in Vietnam, examining the mechanisms of BAI scale-up and the impact of experiential BAI (EBAI) on clinic staff. The two implementation approaches are facilitation only (FAC) and facilitation plus an experiential brief alcohol intervention (EBAI+FAC).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2024

First Posted

April 11, 2024

Study Start

April 25, 2024

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

December 30, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
beginning 9 and continuing for 36 months following publication
Access Criteria
Investigator who proposes to use the data has approved IRB, IEC, or REB and an executed data use/sharing agreement with UNC.

Locations